Fundamentals data is not available for this company.
No recent information was found.
| Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
| Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Currency | US Dollars |
| Share Price | $ 27.98 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $36.00 |
| 52 Week Low | $26.13 |
| Volume | 1,206,634 |
| Shares Issued | 156.88m |
| Market Cap | $4,389.57m |
| RiskGrade | 248 |
You are here: research